Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy
Molecules · 31.03.2024 · 29 (7) · 1564
DOI: 10.3390/molecules29071564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 31.03.2024. Verfasst von Raissa Munderere und 6 weiteren Autor:innen. Beteiligte Einrichtung: Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: Folic Acid, Metal Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Methotrexate (MTX) has poor water solubility and low bioavailability, and cancer cells can become resistant to it, which limits its safe delivery to tumor sites and reduces its clinical efficacy. Herein, we developed novel redox-responsive hybrid nanoparticles (NPs) from hyaluronic acid (HA) and 3-mercaptopropionic acid (MPA)-coated gold NPs (gold@MPA NPs), which were further conjugated with folic acid (FA). The design of FA-HA-ss-gold NPs aimed at enhancing cellular uptake specifically in cancer cells using an active FA/HA dual targeting strategy for enhanced tumor eradication. MTX was successfully encapsulated into FA-HA-ss-gold NPs, with drug encapsulation efficiency (EE) as high as >98.7%. The physicochemical properties of the NPs were investigated in terms of size, surface charges, wavelength reflectance, and chemical bonds. MTX was released in a sustained manner in glutathione (GSH). The cellular uptake experiments showed effective uptake of FA-HA-ss-gold over HA-ss-gold NPs in the deep tumor. Moreover, the release studies provided strong evidence that FA-HA-ss-gold NPs serve as GSH-responsive carriers. In vitro, anti-tumor activity tests showed that FA-HA-ss-gold/MTX NPs exhibited significantly higher cytotoxic activity against both human cervical cancer (HeLa) cells and breast cancer (BT-20) cells compared to gold only and HA-ss-gold/MTX NPs while being safe for human embryonic kidney (HEK-293) cells. Therefore, this present study suggests that FA-HA-ss-gold NPs are promising active targeting hybrid nanocarriers that are stable, controllable, biocompatible, biodegradable, and with enhanced cancer cell targetability for the safe delivery of hydrophobic anticancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Republic of Korea.
- New-Senior Oriented Smart Health Care Education Center (BK21 Plus), Pukyong National University, Busan 48513, Republic of Korea.
- Ashland Specialties Ireland Ltd., N91 F6PD Mullingar, Ireland.
- Department of Smart Green Technology Engineering, Pukyong National University, Busan 48513, Republic of Korea.
- Major of Biomedical Engineering, Division of Smart Healthcare, College of Information Technology and Convergence, Pukyong National University, Busan 48513, Republic of Korea.
- Institute of Display Semiconductor Technology, Pukyong National University, Busan 48513, Republic of Korea.
ORCID-Profile: Seon-Hwa Kim, Kwon Taek Lim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Munderere, R., Gulfam, M., Ali, I., Kim, S. H., Vu, T. T., Park, S. H., & Lim, K. T. (2024). Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy. Molecules, 29(7), 1564. https://doi.org/10.3390/molecules29071564
Vancouver
Munderere R, Gulfam M, Ali I, Kim SH, Vu TT, Park SH, et al. Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy. Molecules. 2024;29(7):1564. doi:10.3390/molecules29071564
BibTeX
@article{Munderere2024,
author = {Munderere, Raissa and Gulfam, Muhammad and Ali, Israr and Kim, Seon-Hwa and Vu, Trung Thang and Park, Sang-Hyug and Lim, Kwon Taek},
title = {Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy},
journal = {Molecules},
year = {2024},
volume = {29},
number = {7},
pages = {1564},
doi = {10.3390/molecules29071564}
}
EUVIMED